Downregulation of Programmed Cell Death 10 (PDCD 10) Expression Confers Doxorubicin Resistance in Breast Cancer Cells

Date

2017-10-08

Author

Mamatoğlu, Çağrı Urfalı
Kazan, Hasan Hüseyin
Gündüz, Ufuk

Metadata

Show full item record

Item Usage Stats

160
views

0
downloads

Dysregulated apoptosis is one of the major drug resistance mechanisms. Programmed cell death 10 (PDCD10) is a novel apoptosis regulator, involving in modulation of apoptosis and cell survival. Despite its importance in apoptotic regulation, the role of PDCD10 in drug resistance has not been understood yet. We screened parental and doxorubicin-resistant MCF7, HeLa and K562 cells for PDCD10 expression. Our results showed that PDCD10 expression is cell-specific; significantly downregulated in MCF7 and upregulated in HeLa whereas there is no significant alteration in K562 cell line when the parental cells acquire resistance to doxorubicin. Transient downregulation of PDCD10 expression resulted in 3 fold increase in IC value of doxorubicin, leading to enhanced resistance in MCF7 cell line. 50 Similarly, overexpression of PDCD10 partially resensitized drug-resistant MCF7 cells to doxorubicin. PDCD10-downregulated parental MCF7 cells were shown to be resistant to apoptosis when exposed to apoptosis inducer, etoposide. Expression levels of anti-apoptotic BCL2 and Survivin increased after PDCD10 silencing, resembling the gene expression pattern of doxorubicin-resistant subline. Moreover, inhibition of PDCD10 expression in MCF7 cell line aggressiveness and led to higher cellular motility which is a characteristic attributed to doxorubicin-resistant cells. Our study showed that PDCD10 expression is cell-specific and inhibition of PDCD10 expression enables doxorubicin resistance in MCF7 breast cancer cells

Subject Keywords

Multidrug resistance, Apoptosis, PDCD10

URI

https://hdl.handle.net/11511/85772

Conference Name

MolBioKon’17, (8 - 10 Eylül 2017)

Collections

Graduate School of Natural and Applied Sciences, Conference / Seminar

Suggestions

OpenMETU
Core

Dual function of programmed cell death 10 (PDCD10) in drug resistance Urfali-Mamatoglu, Cagri; Kazan, Hasan Huseyin; Gündüz, Ufuk (2018-05-01) Drug resistance, a major challenge in cancer chemotherapy, is a result of several mechanistic alterations including resistance to apoptosis. Apoptosis is a well-controlled cell death mechanism which is regulated by several signaling pathways. Alterations in structure, function, and expression pattern of the proteins involved in the regulation of apoptosis have been linked to drug resistance. Programmed Cell Death 10 (PDCD10) protein is recently associated with the regulation of cell survival and apoptosis. ...
Reversal of multidrug resistance in mcf-7 breast adenocarcinoma cell line by silencing interleukin 6 with RNA interference Çakmak, Neşe; Gündüz, Ufuk; Department of Biology (2013) Multidrug resistance (MDR) in cancer is characterized by development of resistance to several unrelated drugs upon long time administration of a certain type of chemotherapeutic agent. In doxorubicin resistant MCF-7 cell line, resistance is developed mainly by upregulation of MDR1 gene which encodes an ABC transporter protein known as P-glycoprotein. Interleukin 6 (IL-6) is a cytokine which acts as a growth factor for certain cell types including some cancer cells. IL-6 is found at high levels in cancer pat...
Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells Alpsoy, Aktan; Gündüz, Ufuk (2015-06-01) Success of chemotherapy is generally impaired by multidrug resistance, intrinsic resistance, or acquired resistance to functionally and structurally irrelevant drugs. Multidrug resistance emerges via distinct mechanisms: increased drug export, decreased drug internalization, dysfunctional apoptotic machinery, increased DNA damage repair, altered cell cycle regulation, and increased drug detoxification. Several reports demonstrated that multidrug resistance is a multifaceted problem such that multidrug resis...
Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance BARAN, YUSUF; Guer, Bala; Kaya, Pelin; Ural, Ali Ugur; Avcu, Ferit; Gündüz, Ufuk (2007-12-01) The major problem in the treatment of acute myeloid leukemia (AML) patients results from multidrug resistance to administered anticancer agents. Drug resistance proteins, MDR1 and MRP1, which work as drug efflux pumps, can mediate the multidrug resistance of human leukemia cells. In this study, the mechanisms of resistance to doxorubicin-induced cell death in human HL60 AML cells were examined.
Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line Mutlu, Pelin; Gündüz, Ufuk (Elsevier BV, 2012-4) Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for many types of cancers including multiple myeloma. It is becoming increasingly apparent that tumor microenvironment could provide a shelter to malignant plasma cells that allow their survival after initial drug exposure. This study demonstrates alterations in gene expression levels of several extracellular matrix (ECM) components in prednisone, vincristine and melphalan-resistant RPMI-8226 myeloma cells. Resistant RP...

Citation Formats

Ç. U. Mamatoğlu, H. H. Kazan, and U. Gündüz, “Downregulation of Programmed Cell Death 10 (PDCD 10) Expression Confers Doxorubicin Resistance in Breast Cancer Cells,” presented at the MolBioKon’17, (8 - 10 Eylül 2017), İstanbul, Türkiye, 2017, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/85772.